Cardiovascular prevention can be provided to patients at different risk levels. The aim of this study was to compare the quality of cardiovascular prevention provided in European primary care between patients with diagnosed coronary heart disease (CHD) and individuals at high risk due to known risk factors but not labelled with a diagnosis of cardiovascular disease (CVD). Additionally, we aimed to identify individual and practice factors to predict risk factor control.
Methods
An international cross-sectional study was conducted in 10 European countries. Clinical record data were abstracted for quality indicators for 8928 patients in 10 countries and patient questionnaires were completed by 7846 patients in nine countries. Information about 320 general practices was assessed using practice questionnaires and interviews. Hierarchical multilevel modelling was used for analyses.
Results
Recording of risk factors and advice was higher in the CHD than in the high-risk group. Risk factor control was better in the CHD group: uncontrolled levels of blood pressure (34.2 vs. 49.3%; p < 0.001), cholesterol (32.4 vs. 64.5%; p < 0.001). Predictors of risk factor control were medication adherence (RR 0.97; p = 0.007) and health-related quality of life (RR 0.86; p = 0.005). Being at high risk (RR 1.42; p < 0.001), being single (RR 1.12; p < 0.001), and having lower educational level (RR 1.09; p < 0.001) were associated with poorer risk factor control. Practice factors were not associated with outcomes.
Conclusions
Strategies to improve guidelines adherence in cardiovascular prevention may be stronger focused on individuals at risk before CVD is diagnosed and require organizational and political support to reinforce general practices.
LealJLuengo-FernandezRGrayA. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J2006; 27: 1610–1619.
2.
WRITING GROUP MEMBERS, Lloyd-Jones D, Adams RJ, Brown TM, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2010 update. Circulation2010; 121: e46–e215.
3.
YusufSHawkenSOunpuuS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet2004; 364: 937–952.
4.
EzzatiMVander HoornSRodgersA. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet2003; 362: 271–280.
AnandSSYusufS. Stemming the global tsunami of cardiovascular disease. Lancet2011; 377: 529–532.
7.
KonesR. Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention. Ther Adv Cardiovasc Dis2011; 5: 61–81.
8.
World Health Organization. World health report 2008: primary health care – now more than ever. Geneva: WHO. Available at: www.who.int/whr/2008/en/index.html (2008, consulted February 2012).
9.
BodenheimerTWagnerEHGrumbachK. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA2002; 288: 1909–1914.
10.
Renders CM, Valk GD, Griffin S, et al. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001; (1): CD001481.
11.
LoboCMFrijlingBDHulscherMEJL. Improving quality of organizing cardiovascular preventive care in general practice by outreach visitors: a randomized controlled trial. Prev Med2002; 35: 422–429.
12.
SzecsenyiJRosemannTJoosS. German diabetes disease management programs are appropriate for restructuring care according to the chronic care model: an evaluation with the patient assessment of chronic illness care instrument. Diabetes Care2008; 31: 1150–1154.
13.
CampbellSMReevesDKontopantelisE. Effects of pay for performance on the quality of primary care in England. New Engl J Med2009; 361: 368–378.
14.
HungDYRundallTGTalliaAF. Rethinking prevention in primary care: applying the chronic care model to address health risk behaviors. Milbank Q2007; 85: 69–91.
15.
GlasgowREOrleansCTWagnerEH. Does the chronic care model serve also as a template for improving prevention?Milbank Q2001; 79: 579–612, iv–v.
16.
FerketBSColkesenEBVisserJJ. Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check?Arch Intern Med2010; 170: 27–40.
17.
TaskFMGrahamIAtarD. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J2007; 28: 2375–2414.
18.
CooperAO’FlynnN. on behalf of the Guideline Development Group. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance. BMJ2008; 336: 1246–1248.
19.
MoscaLLinfanteAHBenjaminEJ. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation2005; 111: 499–510.
20.
BanegasJRLopez-GarciaEDallongevilleJ. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J2011; 32: 2143–2152.
21.
KotsevaKWoodDDe BackerG. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil2009; 16: 121–137.
22.
KotsevaKWoodDDe BackerG. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet2009; 373: 929–940.
23.
CampbellSMLudtSVan LieshoutJ. Quality indicators for the prevention and management of cardiovascular disease in primary care in nine European countries. Eur J Cardiovasc Prev Rehabil2008; 15: 509–515.
24.
LudtSCampbellSVan LieshoutJ. Development and pilot of an internationally standardized measure of cardiovascular risk management in European primary care. BMC Health Serv Res2011; 11: 70–70.
25.
WensingMLudtSCampbellS. European practice assessment of cardiovascular risk management (EPA Cardio): protocol of an international observational study in primary care. ImplementSci2009; 4: 3–3.
26.
Scottish Intercollegiate Guidelines Network. Risk estimation and the prevention of cardiovascular disease. Edinburgh: SIGN. Available at: http://www.sign.ac.uk/pdf/sign97.pdf (2007, consulted February 2012).
27.
CooperAO’FlynnN. on behalf of the Guideline Development Group. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance. BMJ2008; 336: 1246–1248.
28.
ThomsenT. HeartScore: a new web-based approach to European cardiovascular disease risk management. Eur J Cardiovasc Prev Rehabil2005; 12: 424–426.
29.
MoriskyDEGreenLWLevineDM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care1986; 24: 67–74.
30.
DyerMTGoldsmithKASharplesLS. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes2010; 8: 13–13.
31.
EngelsYDautzenbergMCampbellS. Testing a European set of indicators for the evaluation of the management of primary care practices. Fam Pract2006; 23: 137–147.
32.
Rasbash J, Brown W, Healy M, et al. MLwiN version 2.24. Bristol: Centre for Multilevel Modelling, University of Bristol, 2011.
33.
Van LieshoutJWensingMCampbellSM. Primary care strength linked to prevention programs for cardiovascular disease. Am J Manag Care2009; 15: 255–262.
34.
Van LieshoutJGoldfrachtMCampbellS. Primary care characteristics and population-orientated health care across Europe: an observational study. Br J Gen Pract2011; 61: e22–e30.
35.
LudtSPetekDLauxG. Recording of risk-factors and lifestyle counselling in patients at high risk for cardiovascular diseases in European primary care. Eur J Prev Cardiol2012; 19: 258––266.
36.
LudtSWensingMSzecsenyiJ. Predictors of health-related quality of life in patients at risk for cardiovascular disease in European primary care. PLoS ONE2011; 6: e29334–e29334.
37.
DraperD. Inference and hierarchical modeling in the social sciences. J Educ Behav Stati1995; 20: 115–147.
38.
FarleyTADalalMAMostashariF. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med2010; 38: 600–609.
39.
KahnRRobertsonRMSmithR. The impact of prevention on reducing the burden of cardiovascular disease. Circulation2008; 118: 576–585.
40.
SteinbergBABhattDLMehtaS. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J2008; 156: 719–727.
ChecklandKHarrisonSMcDonaldR. Biomedicine, holism and general medical practice: responses to the 2004 General Practitioner contract. Sociol Health Illn2008; 30: 788–803.
43.
Doran T, Kontopantelis E, Valderas JM, et al. Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework. BMJ 2011; 342.
44.
NuttingPADickinsonWPDickinsonLM. Use of chronic care model elements is associated with higher-quality care for diabetes. Ann Fam Med2007; 5: 14–20.
45.
GemmellIHellerRFPayneK. Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies. Qual Saf Health Care2006; 15: 339–343.
46.
GroverSAPaquetSLevintonC. Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention. Arch Intern Med1998; 158: 655–662.
47.
GroverSCoupalLKouacheM. Estimating the benefits of patient and physician adherence to cardiovascular prevention guidelines: the MyHealthCheckup survey. Can J Cardiol2011; 27: 159–166.
48.
Robert C, Jonathan E, Astrid F, et al. Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19,000 men in the Whitehall study. BMJ 2009; 339.
49.
MungerMAVan TassellBWLaFleurJ. Medication nonadherence: an unrecognized cardiovascular risk factor. Med Gen Med2007; 9: 58–58.
50.
SkodovaZNagyovaIvan DijkJ. Socioeconomic differences in psychosocial factors contributing to coronary heart disease: a review. J Clin Psychol Med Settings2008; 15: 204–213.
51.
FriedbergMWColtinKLSafranDG. Associations between structural capabilities of primary care practices and performance on selected quality measures. Ann Intern Med2009; 151: 456–463.
52.
O’ConnorPRushWSolbergL. Variation in quality of diabetes care at the levels of patient, physician, and clinic. Prev Chronic Dis2008; 5: A15–A15.
53.
TsaiACMortonSCMangioneCM. A meta-analysis of interventions to improve care for chronic illnesses. Am J Manag Care2005; 11: 478–488.
54.
AyresCGGriffithHM. Perceived barriers to and facilitators of the implementation of priority clinical preventive services guidelines. Am J Manag Care2007; 13: 150–155.
55.
SolbergLKottkeTConnS. Delivering clinical preventive services is a systems problem. Ann Behav Med1997; 19: 271–278.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
